BioWorld - Wednesday, April 8, 2020

Digital health, BioWorld
%{topic} RSS Feed RSS

3-27-Pear-Somryst.png

FDA authorizes Pear Therapeutics' prescription digital insomnia therapy

March 27, 2020
By Annette Boyle
No Comments
Pear Therapeutics Inc. obtained FDA approval for Somryst, the first prescription digital therapeutic for chronic insomnia. The app provides structured cognitive behavior therapy (CBT) with clinical dashboards for physicians. While CBT is the recommended first-line therapy for insomnia, the U.S. has only 500 therapists certified to provide CBT for insomnia (CBTi) for the estimated 30 million Americans who suffer from chronic difficulty going to and staying asleep.
Read More
Coronavirus-pandemic2

Survey: Chronic disease patients in U.S. start to avoid care settings on coronavirus concerns

March 17, 2020
By Stacy Lawrence
No Comments
Chronic disease patients are facing serious risks both from keeping away from necessary care settings, as well as from potential COVID-19 infection. One in five chronic disease patients was already starting to avoid seeking care in physician’s offices and hospitals, according to a survey that started early last week of a panel of 1,300 chronic disease patients across several indications.
Read More
3-9-Voluntis-app.png

BMS partners with Voluntis to develop oncology digital therapeutics

March 12, 2020
By Stacy Lawrence
No Comments
Pharma has not gotten terribly serious yet about integrating digital health tools into clinical trials, let alone into their product offerings, despite the potential benefits they could offer when it comes to patient adherence, compliance and experience. Still, oncology giant Bristol Myers Squibb Co. has made a small step in that direction by partnering with Paris-based digital therapeutics company Voluntis SA.
Read More
digital-health-electronic-health-record-EHR.png
Digital health developers, telehealth among the winners

CMS, ONC rules for electronic health records largely mirror both drafts

March 10, 2020
By Mark McCarty
No Comments
The Office of the National Coordinator (ONC) and CMS both posted their final rules for electronic health records (EHRs), and analysts with Cowen Washington Research Group said both rules essentially replicate the draft versions. The provisions dealing with data blocking and interoperability are expected to benefit developers of HER systems in the near term, and telehealth should also benefit, albeit over a longer scale of time.
Read More
BioAsia 2020

Digital strategies key for Indian pharma

February 21, 2020
By T.V. Padma
No Comments
HYDERABAD, India – To continue expanding their footprint and capabilities beyond simple generics to biosimilars and new chemical entities, Indian pharmaceutical companies will have to improve their quality controls, compliance capabilities and, just as importantly, adopt more effective digital strategies.
Read More
finance-dollar-growth.png

IDbyDNA snags $20M in series B funding

January 30, 2020
By Meg Bryant
No Comments
IDbyDNA Inc., a San Francisco-based metagenomics technology company, scooped up $20 million in series B financing in a round led by Artis Ventures. Genesys Capital and others participated in the round. The company plans to use the money to accelerate uptake of its Explify software platform.
Read More
Puzzle-pieces-globe.png
Precision Medicine World Conference

Verily highlights diabetes care, Project Baseline even as related partnerships are restructured

January 24, 2020
By Stacy Lawrence
No Comments
SANTA CLARA, Calif. – Diabetes seems likely to be the first area to really show concrete products and results for the ambitious Verily Life Sciences, which is the med-tech business of Mountain View, Calif.-based Google parent Alphabet Inc. However, its two major diabetes partners both have been rethinking the relationship.
Read More

Popular Stories

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe